栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/10/31 | 2,528 | 2,539 | 2,477 | 2,479 | -10 | -0.4% | 141,000 |
| 2024/10/30 | 2,494 | 2,502 | 2,464 | 2,489 | +27 | +1.1% | 407,200 |
| 2024/10/29 | 2,471 | 2,471 | 2,437 | 2,462 | +7 | +0.3% | 68,800 |
| 2024/10/28 | 2,432 | 2,473 | 2,429 | 2,455 | +23 | +0.9% | 62,900 |
| 2024/10/25 | 2,478 | 2,486 | 2,419 | 2,432 | -38 | -1.5% | 111,100 |
| 2024/10/24 | 2,485 | 2,489 | 2,459 | 2,470 | -36 | -1.4% | 89,000 |
| 2024/10/23 | 2,510 | 2,540 | 2,490 | 2,506 | -9 | -0.4% | 68,000 |
| 2024/10/22 | 2,547 | 2,550 | 2,497 | 2,515 | -37 | -1.4% | 75,300 |
| 2024/10/21 | 2,560 | 2,568 | 2,530 | 2,552 | +5 | +0.2% | 103,900 |
| 2024/10/18 | 2,504 | 2,561 | 2,504 | 2,547 | +47 | +1.9% | 125,300 |
| 2024/10/17 | 2,461 | 2,508 | 2,454 | 2,500 | +34 | +1.4% | 119,400 |
| 2024/10/16 | 2,462 | 2,493 | 2,455 | 2,466 | -13 | -0.5% | 78,300 |
| 2024/10/15 | 2,477 | 2,493 | 2,464 | 2,479 | +24 | +1% | 73,500 |
| 2024/10/11 | 2,470 | 2,475 | 2,454 | 2,455 | -2 | -0.1% | 61,700 |
| 2024/10/10 | 2,457 | 2,461 | 2,424 | 2,457 | ±0 | ±0% | 62,600 |
| 2024/10/09 | 2,459 | 2,470 | 2,448 | 2,457 | ±0 | ±0% | 66,400 |
| 2024/10/08 | 2,428 | 2,457 | 2,412 | 2,457 | -3 | -0.1% | 72,600 |
| 2024/10/07 | 2,468 | 2,477 | 2,433 | 2,460 | ±0 | ±0% | 70,400 |
| 2024/10/04 | 2,435 | 2,464 | 2,433 | 2,460 | +42 | +1.7% | 100,300 |
| 2024/10/03 | 2,400 | 2,432 | 2,400 | 2,418 | +52 | +2.2% | 68,700 |
| 2024/10/02 | 2,353 | 2,371 | 2,330 | 2,366 | +10 | +0.4% | 79,900 |
| 2024/10/01 | 2,346 | 2,371 | 2,327 | 2,356 | +32 | +1.4% | 62,900 |
| 2024/09/30 | 2,345 | 2,356 | 2,301 | 2,324 | -71 | -3% | 93,600 |
| 2024/09/27 | 2,410 | 2,439 | 2,355 | 2,395 | -25 | -1% | 138,200 |
| 2024/09/26 | 2,389 | 2,422 | 2,355 | 2,420 | +59 | +2.5% | 166,300 |
| 2024/09/25 | 2,357 | 2,369 | 2,322 | 2,361 | +4 | +0.2% | 79,900 |
| 2024/09/24 | 2,369 | 2,379 | 2,333 | 2,357 | -12 | -0.5% | 81,600 |
| 2024/09/20 | 2,376 | 2,376 | 2,330 | 2,369 | -11 | -0.5% | 101,200 |
| 2024/09/19 | 2,401 | 2,410 | 2,370 | 2,380 | -5 | -0.2% | 57,200 |
| 2024/09/18 | 2,360 | 2,390 | 2,356 | 2,385 | +40 | +1.7% | 58,400 |
| 2024/09/17 | 2,330 | 2,346 | 2,319 | 2,345 | +40 | +1.7% | 50,900 |
| 2024/09/13 | 2,338 | 2,340 | 2,286 | 2,305 | -21 | -0.9% | 77,900 |
| 2024/09/12 | 2,339 | 2,349 | 2,312 | 2,326 | +30 | +1.3% | 55,900 |
| 2024/09/11 | 2,349 | 2,360 | 2,285 | 2,296 | -54 | -2.3% | 51,100 |
| 2024/09/10 | 2,342 | 2,358 | 2,314 | 2,350 | +27 | +1.2% | 34,200 |
| 2024/09/09 | 2,294 | 2,339 | 2,277 | 2,323 | -3 | -0.1% | 45,600 |
| 2024/09/06 | 2,298 | 2,332 | 2,286 | 2,326 | +48 | +2.1% | 51,600 |
| 2024/09/05 | 2,300 | 2,329 | 2,268 | 2,278 | -37 | -1.6% | 64,200 |
| 2024/09/04 | 2,288 | 2,324 | 2,281 | 2,315 | +11 | +0.5% | 92,000 |
| 2024/09/03 | 2,297 | 2,320 | 2,285 | 2,304 | +33 | +1.5% | 49,900 |
| 2024/09/02 | 2,289 | 2,305 | 2,256 | 2,271 | -25 | -1.1% | 46,500 |
| 2024/08/30 | 2,296 | 2,306 | 2,253 | 2,296 | +39 | +1.7% | 92,600 |
| 2024/08/29 | 2,287 | 2,306 | 2,239 | 2,257 | -17 | -0.7% | 107,200 |
| 2024/08/28 | 2,238 | 2,287 | 2,238 | 2,274 | -4 | -0.2% | 32,700 |
| 2024/08/27 | 2,280 | 2,301 | 2,258 | 2,278 | +25 | +1.1% | 62,100 |
| 2024/08/26 | 2,273 | 2,283 | 2,252 | 2,253 | -20 | -0.9% | 48,400 |
| 2024/08/23 | 2,285 | 2,289 | 2,250 | 2,273 | -11 | -0.5% | 44,300 |
| 2024/08/22 | 2,266 | 2,293 | 2,261 | 2,284 | +31 | +1.4% | 39,400 |
| 2024/08/21 | 2,224 | 2,253 | 2,206 | 2,253 | +13 | +0.6% | 58,000 |
| 2024/08/20 | 2,255 | 2,276 | 2,223 | 2,240 | -7 | -0.3% | 59,000 |
201～
250
件表示中 / 7025件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 247,000円 | +4.1% | -3.1% | 2.35% | 21.46倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| 持田薬 | 314,500円 | +5.1% | -7.0% | 2.54% | 20.65倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 203,600円 | +3.1% | -6.5% | 2.36% | 9.45倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 152,000円 | -2.4% | -52.3% | 3.75% | 18.19倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ネクセラファーマ | 91,300円 | +20.3% | - | 0.00% | 161.88倍 | 1.25倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
